Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,189.50    -7.00 (-0.59%)
Bid:
1,185.00
Ask:
1,186.50
Spread: 1.50 (0.127%)
Market Cap: £6.05b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

25 Oct 2017 09:23

St. James’s Place plc (β€œSJP”)

SJP was notified on 24 October 2017 of the following changes in SJP shares held by the Executive Directors named below.

SJP Performance Share Plan 2005 (β€œPSP”) and linked Company Share Option Plan 2010 (β€œCSOP”)

CSOP

On 26 March 2014 the following Executive Directors (β€œthe Directors”) were awarded a CSOP-linked award, whereby they were granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC-approved CSOP share option:

Andrew Croft, Chief Financial Officer

Ian Gascoigne, Managing Director

David Lamb, Managing Director

The Directors exercised the linked CSOP award on 24 October 2017 with an exercise price of Β£8.515 per share and, as a result, their linked PSP awards automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 24 October 2017, and column 2 sets out the number of SJP shares sold on 24 October 2017 at Β£11.81 pence per share by the Directors. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of these exercises, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

CSOP 1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SJP shares retained under the linked PSP award
Andrew Croft 3,054 3,054 853 72,312
Ian Gascoigne 3,054 2,632 853 72,312
David Lamb 3,054 3,054 853 72,312

PSP

On 26 March 2014 the Directors were awarded nil cost unapproved PSP awards. On 24 October 2017 the Directors exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 24 October 2017 at a price of Β£11.72 pence per share by the Directors in order to settle income tax and National Insurance liabilities, and column 3 sets out the number of additional SJP shares sold by the Directors at Β£11.72. Column 4 sets out the number of SJP shares retained.

PSP 1 2 3 4
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of Additional SJP Shares Sold Number of SJP shares retained
Andrew Croft 72,312 33,987 19,210 19,115
Ian Gascoigne 72,312 33,987 19,210 19,115
David Lamb 72,312 33,987 38,325 0

Following the above transactions, Ian Gascoigne gifted at nil cost 19,537 SJP shares to Gail Gascoigne, a Person Closely Associated with him, on 24 October 2017.

This notification is made in accordance with EU Market Abuse Regulation.

LEI: 213800M993ICXOMBCP87

Classification: 3.1 Additional regulated information required to be disclosed under the laws of a Member State

Deputy Company Secretary, Tel: +44 (0)1285 717237

25 October 2017

View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005470/en/

Copyright Business Wire 2017

Date   Source Headline
1st Jun 20269:34 amRNSTotal Voting Rights
26th May 20264:10 pmRNSDirector/PDMR Shareholding
20th May 202612:04 pmRNSHolding(s) in Company
20th May 20267:00 amRNSAdmission to Trading
15th May 20263:47 pmRNSDirector/PDMR Shareholding
11th May 20261:59 pmRNSDirector/PDMR Shareholding
6th May 20263:26 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20269:30 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:00 pmRNSResult of AGM
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSQ1 New Business Inflows & Funds Under Management
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202611:52 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 20262:50 pmRNSAdmission of Further Securities to Trading
25th Mar 202612:07 pmRNSCorrection: Transaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:25 pmRNSNotice of AGM
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20263:41 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 202611:08 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.